Truist Securities boosted the price target for BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $125 to $140. Truist Securities analyst Robyn Karnauskas maintained a Buy rating. BioMarin Pharmaceutical shares fell 3.6% to close at $88.93 on Thursday.
NSW winery moves to digital currency
December 18th, 2020
On the back of a Victorian winery moving to digital currency, Mudgee winery, Skimstone Wines, has also turned to Qoin as a means to market to domestic tourists and businesses and drive wine sales.
The award-winning winery, which produces Chardonnay, Merlot, Cabernet Shiraz and Cabernet Merlot, along with the popular Italian varietals of Barbera, Sangiovese and Sangiovese Rose, lost its entire 2020 vintage due to bushfires.
Now also facing the ongoing impacts of COVID-19, which has decimated international tourism, Skimstone Wines will need to move existing stock to survive the next two years as the vines regenerate.